Hyundai Pharmaceutical

004310 · KOSPI · Health Care · SMALL CAP

Quarterly report (2026.08)

(Quarterly report (2026.08))· FILED 2026-10-15· RCEPT 20261015000435

About this filing

The quarterly report: reviewed financial statements and a business update for the quarter.

Why companies file it: Listed companies must file it within 45 days of each quarter end (Q1 and Q3).

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-10-15, Quarterly report (2026.08)
SourceDART rcept 20261015000435 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-10-15 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).